Skip to main content

Resource Download
US and Canada - Outlook and implications of pricing reforms in North America

11th EPP Life Sciences Forum - October 2022 - Zurich (Switzerland)

  • USA: Overview of US drug pricing initiatives, regulatory proposals, potential for implementation in current political environment
  • Canada: New reference countries and new pricing Guidelines
  • Implications of Canadian (and potentially US) international Reference Pricing (IRP)
  • Prospects for Canada – US cross-border trade: myth vs fact
  • National policies and the Biopharmaceutical Ecosystem Index
  • Outlook and implications

EPP Prime+ Required to access this resource

Join EPP Prime+ now and get direct access to the best resources, weekly updated with new content, webinars, dynamic talks, tools from the EPP Community.

Subscribe your team and benefit from important group discounts

EPP Prime+
Back